IP Library › Assignment 056193/0437
Patent Assignment
Reel/Frame 056193/0437

Change of Name

Recorded: 2021-05-10 Pages: 5
Assignor
AEGERION PHARMACEUTICALS, INC.
Executed: 2021-03-16
Assignee
AMRYT PHARMACEUTICALS, INC.
ONE MAIN STREET, SUITE 800, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Properties (5)
A Chimeric Leptin Polypeptide and Method of Using the Same
Application: 14/703,523 →
Publication: US 2016/0083446
Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity
Patent: 9,879,063 →
Application: 14/837,705 →
Publication: US 2016/0207974
Compound Impurities and Methods of Detecting Same
Application: 15/570,246 →
Publication: US 2018/0133205
Methods of Detecting Anti-Leptin Neutralizing Antibodies
Application: 15/702,719 →
Publication: US 2018/0074073
Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity
Application: 15/882,919 →
Publication: US 2018/0305430
Related Assignments (14)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement Sep 24, 2018
From: AEGERION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS AGENT
Reel/Frame 047130/0176 →
Patent Security Agreement Nov 8, 2018
From: AEGERION PHARMACEUTICALS, INC.
To: NOVELION THERAPEUTICS INC.
Reel/Frame 047455/0385 →
Security Interest Nov 8, 2018
From: AEGERION PHARMACEUTICALS, INC.
To: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
Reel/Frame 047447/0926 →
Release of Security Interest Nov 12, 2018
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 047474/0398 →
Assignment of Assignor's Interest Jan 20, 2019
From: GELORMINI, ANN
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 048064/0178 →
Release of Security Interest Sep 24, 2019
From: NOVELION THERAPEUTICS INC. (F/K/A QLT, INC.)
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 050478/0738 →
Security Interest Sep 24, 2019
From: AEGERION PHARMACEUTICALS, INC.
To: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
Reel/Frame 050478/0204 →
Release of Security Interest Sep 24, 2019
From: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 050478/0629 →
Release of Security Interest Sep 24, 2019
From: NOVELION THERAPEUTICS INC.
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 050478/0695 →
Release of Security Interest Sep 24, 2019
From: NOVELION THERAPEUTICS INC.
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 050478/0844 →
Assignment of Assignor's Interest May 6, 2020
From: SAILSTAD, JEFFREY
To: AEGERION PHARMACEUTICALS, INC.
Reel/Frame 052590/0679 →
Security Interest Feb 18, 2022
From: AMRYT PHARMACEUTICALS, INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 059049/0164 →
Release of Security Interest Feb 23, 2022
From: CANTOR FITZGERALD SECURITIES, AS ADMINISTRATIVE AGENT
To: AEGERION PHARMACEUTICALS, INC.; AMRYT RESEARCH LIMITED
Reel/Frame 059074/0604 →
Release of Security Interest Apr 13, 2023
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: AMRYT GENETICS LIMITED; AMRYT PHARMACEUTICALS, INC.; AMRYT ENDO, INC.; AMRYT RESEARCH LIMITED
Reel/Frame 063318/0849 →